Abstract

Bioengineered spider silk is a biomaterial that has exquisite mechanical properties, biocompatibility, and biodegradability. Iron oxide nanoparticles can be applied for the detection and analysis of biomolecules, target drug delivery, as MRI contrast agents and as therapeutic agents for hyperthermia-based cancer treatments. In this study, we investigated three bioengineered silks, MS1, MS2 and EMS2, and their potential to form a composite material with magnetic iron oxide nanoparticles (IONPs). The presence of IONPs did not impede the self-assembly properties of MS1, MS2, and EMS2 silks, and spheres formed. The EMS2 spheres had the highest content of IONPs, and the presence of magnetite IONPs in these carriers was confirmed by several methods such as SEM, EDXS, SQUID, MIP-OES and zeta potential measurement. The interaction of EMS2 and IONPs did not modify the superparamagnetic properties of the IONPs, but it influenced the secondary structure of the spheres. The composite particles exhibited a more than two-fold higher loading efficiency for doxorubicin than the plain EMS2 spheres. For both the EMS2 and EMS2/IONP spheres, the drug revealed a pH-dependent release profile with advantageous kinetics for carriers made of the composite material. The composite spheres can be potentially applied for a combined cancer treatment via hyperthermia and drug delivery.

Highlights

  • Cancer is one of the major causes of death worldwide

  • The results showed that the MS1/IONP, MS2/IONP, and EMS2/IONP carriers contained iron oxide nanoparticles

  • We investigated a composite material made of bioengineered spider silk and iron oxide nanoparticles

Read more

Summary

Introduction

Cancer is one of the major causes of death worldwide. Chemotherapy, which is one of the most common cancer treatments, is often restricted by the resistance of cancer cells to chemotherapeutic drugs [1]. Due to the low efficiency of the targeted delivery, the anticancer drugs have toxic side effects by causing damage to healthy tissues.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call